Forget Rigetti Computing: Serious Investors Are Placing Their Chips on This Enterprise‑Ready Quantum Platform

IBM reported strong Q4 2025 results with revenue up 12% YoY to $19.7 billion, net income up 91% to $5.6 billion and diluted EPS rising 88% YoY; full-year 2025 revenue rose 8%, net income +76% and diluted EPS +74%. The company is advancing its quantum roadmap—operating 2,299 qubits in the cloud, owning the largest machine at 1,121 qubits, and unveiling the scalable 120‑qubit Nighthawk processor (30% more complexity, 20% more inter‑qubit connections)—while institutional holders (e.g., Vanguard, Fidelis, Fortis) boosted positions and the stock jumped ~5% on the results. Management targets a 100,000‑qubit system by 2033, positioning IBM as a leader in quantum computing with potential cybersecurity implications for encryption and clear justification for recent investor bullishness.

Analysis

Market structure: IBM's Nighthawk (120 qubits) and its claim to 1,121-qubit systems tilt near-term winners toward IBM (IBM) and large cloud partners (MSFT, Azure) who can bundle quantum access; smaller pure‑play quantum names (RGTIW, QBTS) face pricing pressure and investor rotation out of high‑beta experimental plays. Supply–demand is still demand-constrained for commercial workloads — Nighthawk raises available compute but meaningful enterprise traction will be measured in quarters (next 2–12 months) as IBM exposes capacity to customers. Cross‑asset: stronger tech earnings and institutional buying raise risk‑on bias — expect modest upward pressure on yields, tighter IG spreads, lower safe‑haven flows into USD/JPY in risk rallies, and increased implied vols on long-dated options around public availability announcements.

Risk assessment: Tail risks include a proven cryptographic break (low probability, catastrophic for data/financial systems), regulatory intervention over market power, or a scaling failure in qubit fidelity; each could move IBM shares +/-30–50% in 6–18 months. Immediate (days) risk is post‑earnings consolidation after the ~5% pop; short term (weeks–months) hinge on announcements of public Nighthawk access or large enterprise wins; long term (years to 2033) depends on sustained fidelity improvements and supply chain for cryogenics/interconnects. Hidden dependencies: third‑party fabs, talent retention, and enterprise adoption cycles (procurement lead times of 6–18 months) are critical second‑order risks. Key catalysts: public Nighthawk availability, MSFT/AWS partnership, and one or two marquee commercial use‑cases within 6–12 months.

Key Decisions for Investors

• Establish a 2–3% portfolio long in IBM (IBM) via a 9–18 month call‑spread (buy 9–12 month ITM call, sell 15–18 month OTM call) to capture Nighthawk public access and FY2026 enterprise wins; target +30–50% upside, set a hard stop of -20% if IBM misses two consecutive roadmap milestones or guides revenue down >5% QoQ.
• Implement a relative value pair: long IBM 2% / short Rigetti (RGTIW) 1–1.5% to exploit execution and balance‑sheet advantages; trim the pair if RGTIW raises >$200m in strategic capital or announces a major cloud partnership within 90 days.
• Buy 12–24 month protection (puts) or hedge exposure by overweighting cybersecurity/post‑quantum vendors (1–2% net) — enter cyber longs on pullbacks of 5–12% and increase if public cryptanalysis headlines appear; expect re‑rating within 6–18 months.
• If already long IBM shares, sell 1–3 month covered calls (roll monthly) to harvest premium through potential near‑term consolidation; redeploy proceeds into long‑dated call spreads on IBM or small positions in MSFT (1–2%) as a strategic cloud partner hedge.